Like many scientific bodies, ICNIRP has faced criticisms and controversies. Some stakeholders argue that its guidelines are too conservative or not sufficiently protective, while others claim they hinder technological advancements. These debates mirror those in toxicology, where the balance between safety and innovation must be carefully managed. Transparency and ongoing research are key to addressing such concerns.
